23andMe Lays Off 40% of Its Workforce as Company Spirals
The genetic testing company 23andMe announced it was laying off more than 200 employees, or roughly 40% of its entire workforce, according to a press release Monday. The move is part of a restructuring that will see the company also halt the development of its therapeutics division which had been working on various potential medical treatments.
In the wake of a big data breach and a sizable new round of layoffs, 23andMe's handling of sensitive personal data is in the ...
More than 200 employees of 23andMe are being laid off as part of the company’s ongoing cost-cutting measures. The layoffs ...
Hosted on MSN23h
23andMe to Cut 40% of Its Staff Amid Grim FinancialsIf you buy through affiliate links, we may earn commissions, which help support our testing. DNA testing company 23andMe is ...
23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
The genealogy company’s CEO announced over 200 employees will be let go and it will also shutter its drug-development arm. I ...
23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...
23andMe on Tuesday reported that second-quarter revenue fell to $44.1 million from $50 million a year earlier. The ...
To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. 23andMe said Monday it will lay ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback